Bridging Program 1 creates a connection between technological innovation and translational application. It focuses on using advanced analytics to research and offer preventive or interceptive treatments, as well as developing precision diagnostics with AI support. We will develop and test innovative early diagnosis and treatment strategies for maladaptive diseases in large patient groups, based on our growing understanding of health-supporting signaling networks and the critical transition between health and disease, and aim to integrate these methods into standard care during the ImmunoPreCept program.